Quantcast

Latest cardiovascular disease Stories

2014-09-29 23:03:55

Rev. Michael Bernard Beckwith, Bishop Noel Jones and Dick Gregory Support The Sara Soulati Health For Life Program With EECP to As Way of Lifestyle Modification Los Angeles CA (PRWEB) September 29, 2014 Sara Soulati, CEO and Founder of Global Cardio Care, Inc., the firm that manages physician practices delivering Enhanced External Counterpulsation (EECP), is aligning with African-American church leaders and activists to further spread a heart health message of prevention and lifestyle...

2014-09-24 16:25:59

GENEVA, September 24, 2014 /PRNewswire/ -- AF is the most common type of heart arrhythmia in the world, responsible for 15 - 20 per cent of strokes which affect the brain The World Heart Federation (WHF) is delighted to announce a charitable donation from the pharmaceutical companies Bristol-Myers Squibb and Pfizer. The donation will support a program aimed at engaging patients with atrial fibrillation (AF) and their carers, along with...

heart attack
2014-09-24 03:00:37

Rachel Cagan, American College of Cardiology Four out of five heart attacks may be prevented with healthy behaviors Following a healthy lifestyle, including maintaining a healthy weight and diet, exercise, not smoking and moderating alcohol intake, could prevent four out of five coronary events in men, according to a new study publishing Sept. 22 in the Journal of the American College of Cardiology. While mortality from heart disease has declined in recent decades, with much of the...

2014-09-22 23:10:35

At the 10th Clinton Global Initiative Annual Meeting, the nonprofit Seafood Nutrition Partnership announced the successful launch of a pilot program called Eating Heart Healthy: A Cardiovascular Risk Reduction Program for Women. New York, NY (PRWEB) September 22, 2014 At the 10th Clinton Global Initiative (CGI) Annual Meeting, the nonprofit Seafood Nutrition Partnership (SNP) announced the successful launch of a pilot program called Eating Heart Healthy: A Cardiovascular Risk Reduction...

2014-09-17 08:30:11

- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments - PARIS and SOUTH SAN FRANCISCO, Calif., Sept. 17, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic heart disease, announced today a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most...

2014-09-17 08:28:32

ZUG, Switzerland, Sept. 17, 2014 /PRNewswire/ -- Cardiorentis AG, a privately held biopharmaceutical company, today announced that it has entered into a EUR45 million financing agreement with HealthCare Royalty Partners ("HC Royalty"), a U.S. based healthcare investment firm. The proceeds will be used to finance the Company's registration program for the natriuretic peptide Ularitide in acute heart failure. "This is a pivotal time for our Company. The team at HC Royalty understood...

2014-09-15 20:21:56

WOODBRIDGE, ON, Sept. 15, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that the Board of Directors approved the granting of stock options to an officer and an advisor at the close of business on Friday, September 12, 2014. Options to acquire a total of 1,000,000 common shares of the Company were...

2014-09-15 12:27:22

Tiara(TM) Transcatheter Mitral Valve program featured in multiple scientific presentations NASDAQ: NVCNTSX: NVC WASHINGTON, DC, Sept. 15, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) announced today that its Reducer(TM) technology was featured in a "live case" broadcast on Sunday, September 14, 2014 at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. A Clinical update on the company's Tiara(TM)...

2014-09-10 16:26:00

WOODBRIDGE, ON, Sept. 10, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today the publication of results of a prospective randomized controlled trial in the U.S. that evaluated the effects of VASCAZEN(®) in the correction of Omega-3 deficiency in patients with one or more risk factors associated...

2014-09-10 08:32:05

Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease MARLBOROUGH, Mass., Sept. 10, 2014 /PRNewswire/ -- Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for life and to developing innovative therapies in interventional cardiology. The company will share results from more than a dozen clinical studies at the 26th Transcatheter...


Latest cardiovascular disease Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin